Category: News

ChromaGenix and Sunresin Partner to Expand Access to AAV Purification Technologies in Asia

ChromaGenix and Sunresin have announced a new partnership to expand access to AAV purification technologies for cell and gene therapy developers across Asia. The collaboration supports ChromaGenix’s continued growth and strengthens regional access to advanced chromatography solutions, commercial engagement and technical support for customers working in viral vector manufacturing. Through the partnership, Sunresin will support […]

ChromaGenix Expands Commercial Expertise across USA and Europe with New Appointments

ChromaGenix is expanding its commercial leadership team with two senior appointments that bring decades of experience in bioprocessing and biotechnology. These hires reinforce the company’s commitment to supporting customers worldwide with the scale-up and commercialization of advanced purification technologies. Michael Kaleja joins ChromaGenix as EU Business Development Consultant, bringing more than 40 years of expertise in bioprocessing, […]

Form Title or Action Step

Put the form here instead of this text box.

Linkedin-in

Chris Major

CEO

Chris is responsible for identifying investment opportunities, assessing strategic fit within the portfolio, and supporting growth-related operational initiatives. A serial entrepreneur with over 20 years of bioprocessing experience, he has deep expertise across upstream and downstream technologies. Prior to BioProcess360, he founded and led the Purolite Bioprocessing division, growing it from zero revenue in 2015 to $80M in six years. The business was acquired by Ecolab (NYSE: ECL) in 2021 for $3.7BN. Earlier, Chris helped pioneer single-use technology at WAVE Bioreactors, later acquired by GE Healthcare (now Cytiva), and held senior roles at GE and Merck Millipore. He holds an MSc in Biotechnology and attended Harvard Business School. Outside work, Chris enjoys biking, paddleboarding, live music, and spending time with his two daughters.